objectives the aim of this study was to study the incremental cost-effectiveness ratio associated with the use of heat and moisture exchangers (hme) filter to prevent vap compared with the heated humidifiers (hh) presently adopted by intensive care unit (icu) services within the brazilian healthcare unified system. patients and methods this study was a cost-effectiveness analysis (cea) comparin...

measuring the performance of a production system has been an important task in management for purposes of control, planning, etc. lord kelvin said :“when you can measure what you are speaking about, and express it in numbers, you know something about it; but when you cannot measure it, when you cannot express it in numbers, your knowledge is of a meager and unsatisfactory kind.” hence, manageme...

background and aims: nowadays, hypnosis has opened its position in the medical community. based on controlled trials, hypnosis has been superior compared to other interventional procedures to reduce acute pain. this investigation aims to determine the effectiveness of hypnosis in the treatment of pain and enhancing mental performance in iran, using the meta-analysis method. methods: the search ...

In the past 20 years, there has been increasing recognition of the need to consider cost in medical decision making. This period has seen an explosion in the number of economic evaluations appearing in the medical literature. Cost-effectiveness analysis is an objective systematic technique for comparing alternative health care strategies on both cost and effectiveness simultaneously. Cost-effec...

Economic evaluations in cancer have become increasingly important because of the rising incidence of the disease and the proliferation of effective therapies. The aging of the population and the increasing costs of care make it even more important to identify those treatments of greatest value from both an effectiveness and cost perspective. Economic research can be conducted at the "macro" lev...

Despite the many advances in cardiovascular therapeutics over the last two decades, the incidence of death or myocardial infarction in the six months following clinical presentation with acute coronary syndromes (ACS) (excluding ST elevation myocardial infarction) remains unacceptably high at 12–15% (fig 1). Most ACS trials have focused on reducing ischaemic events during the in-hospital treatm...

The Medicare program has been a notable holdout in the global movement toward the use of cost-effectiveness analysis to inform health care decisions. Unlike the reimbursement authorities in Canada and Australia, and in many countries in Europe, Medicare officials do not formally consider cost-effectiveness when determining the coverage of new medical interventions, even as they also confront ev...